Payments to Acquire Property, Plant, and Equipment in USD of Amylyx Pharmaceuticals, Inc. from Q1 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Amylyx Pharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2021 to Q1 2025.
  • Amylyx Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $11K, a 83.6% decline year-over-year.
  • Amylyx Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $157K, a 87.3% decline from 2023.
  • Amylyx Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1.24M, a 50.9% decline from 2022.
  • Amylyx Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $2.53M, a 616% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

Amylyx Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $11K -$56K -83.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $67K -$183K -73.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $250K -$92K -26.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $342K +$328K +2343% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $14K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

Amylyx Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $157K -$1.08M -87.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $1.24M -$1.29M -50.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 $2.53M +$2.17M +616% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $353K Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.